Next Article in Journal
Viral Hepatitis B and C. Cure or Treatment?
Previous Article in Journal
Primary Prevention of Hemoglobinopathies by Prenatal Diagnosis and Selective Pregnancy Termination in a Muslim Country: Oman
 
 
Thalassemia Reports is published by MDPI from Volume 12 Issue 1 (2022). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with PAGEPress.
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Low Bone Mineral Density in Thalassemia Major: Sanjay Gandhi Post Graduate Institute Experience and a Brief Focus on Underlying Factors behind the Cause

by
Kritanjali Singh
1,
Sarita Agarwal
1,* and
Sushil Gupta
2
1
Department of Medical Genetics, Sanjay Gandhi Post Graduate Institute of Medical Sciences, Lucknow 226014, India
2
Department of Endocrinology, Sanjay Gandhi Post Graduate Institute of Medical Sciences, Lucknow 226014, India
*
Author to whom correspondence should be addressed.
Thalass. Rep. 2014, 4(1), 2104; https://doi.org/10.4081/thal.2014.2104
Submission received: 1 November 2013 / Revised: 28 May 2014 / Accepted: 12 June 2014 / Published: 25 November 2014

Abstract

Thalassemia major is a genetic disorder and blood transfusion is critical for survival in these patients. Over the course of the past three decades, hyper transfusion therapy in these patients has shown has dramatically extended life expectancy and improved quality of life. Unfortunately, this type of therapy also increased the incidence of complications due to iron overload. The aim of this study was to assess bone mineral density (BMD) in patients with β-thalassemia major and to determine their biochemical and hormonal profiles that may affect BMD. A cross- sectional study was carried out in Sanjay Gandhi—PGIMS, a tertiary care hospital over period of 3 years on all β-thalassemia major patients above 7 years receiving regular transfusion. Patients with transfusion dependent anaemia other than β thalassemia major were excluded. Physical examination, laboratory tests and bone density measurements were performed. Then, the data were analyzed. The total number of children over 7 years of age with β-thalassemia major receiving regular blood transfusions during the study period was 150. Mean hemoglobin was 7.8 ± 0.6 g/dL and the mean serum ferritin level 5295 ± 2736 ng/mL. Short stature was seen in 54.7% boys and 28.7% of girls. Prevalence of lumbar osteoporosis and osteopenia were 42.5% and 37.5%. Femoral osteoporosis and osteopenia were present in 32.5% and 55% of the patients. Impaired puberty, hypothyroidism, diabetes mellitus, hypoparathyroidism were observed in 26%, 18%, 7%, and 15%, of patients, respectively. Nearly 75% of patients had low bone mineral density. Bone mineral density was significantly associated with short stature (p = 0.002), hypogonadism (p = 0.006), hypoparathyroidism (p = 0.038), hypothyroidism (p = 0.044) and vitamin D deficiency (p < 0.001). High prevalence of complications among our thalassemics signifies the importance of more detailed studies along with therapeutic interventions.
Keywords: thalassemia; endocrinology; anemia thalassemia; endocrinology; anemia

Share and Cite

MDPI and ACS Style

Singh, K.; Agarwal, S.; Gupta, S. Low Bone Mineral Density in Thalassemia Major: Sanjay Gandhi Post Graduate Institute Experience and a Brief Focus on Underlying Factors behind the Cause. Thalass. Rep. 2014, 4, 2104. https://doi.org/10.4081/thal.2014.2104

AMA Style

Singh K, Agarwal S, Gupta S. Low Bone Mineral Density in Thalassemia Major: Sanjay Gandhi Post Graduate Institute Experience and a Brief Focus on Underlying Factors behind the Cause. Thalassemia Reports. 2014; 4(1):2104. https://doi.org/10.4081/thal.2014.2104

Chicago/Turabian Style

Singh, Kritanjali, Sarita Agarwal, and Sushil Gupta. 2014. "Low Bone Mineral Density in Thalassemia Major: Sanjay Gandhi Post Graduate Institute Experience and a Brief Focus on Underlying Factors behind the Cause" Thalassemia Reports 4, no. 1: 2104. https://doi.org/10.4081/thal.2014.2104

Article Metrics

Back to TopTop